FDA Adverse Event Malfunction Summary report: N

ANALYTICAL P MODULE

MDR report key: 1844260 · Received September 24, 2010

Report

Report Number
1823260-2010-05695
Event Type
Malfunction
Date Received
September 24, 2010
Date of Event
September 10, 2010
Report Date
September 24, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K953239
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE RESULTS FOR FERRITIN ON THE ANALYTICAL P MODULE FOR TWO PATIENT SAMPLES. PATIENT SAMPLE 1, THE INITIAL FERRITIN RESULT GAVE 12 PG/ML. THIS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE SAMPLE WAS REPEATED GIVING 23 PG/ML. PATIENT SAMPLE 2, THE INITIAL FERRITIN RESULT GAVE 21 PG/ML. THIS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE SAMPLE WAS REPEATED GIVING 39 PG/ML. NO ADVERSE EVENT HAS BEEN ALLEGED REGARDING THESE DISCREPANCIES. THE FERRITIN REAGENT LOT NUMBER WAS 62168101 ALTHOUGH THE FIELD APPLICATION SPECIALIST (FAS) COULD NOT DETERMINE A CAUSE, IT WAS NOTED MANY BUBBLES WERE FOUND IN THE FERRITIN R1 REAGENT PACK WHICH COULD INDICATE A REAGENT HANDLING OR SHIPMENT ISSUE AS THE CAUSE. THE FAS RAN PERFORMANCE TESTING WITH ALL RESULTS WITHIN SPECIFICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANALYTICAL P MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1